David B. Clemow

1.2k total citations
40 papers, 883 citations indexed

About

David B. Clemow is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Epidemiology. According to data from OpenAlex, David B. Clemow has authored 40 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 11 papers in Cognitive Neuroscience and 7 papers in Epidemiology. Recurrent topics in David B. Clemow's work include Attention Deficit Hyperactivity Disorder (13 papers), Neural and Behavioral Psychology Studies (11 papers) and Functional Brain Connectivity Studies (7 papers). David B. Clemow is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Neural and Behavioral Psychology Studies (11 papers) and Functional Brain Connectivity Studies (7 papers). David B. Clemow collaborates with scholars based in United States, United Kingdom and Japan. David B. Clemow's co-authors include Jeremy B. Tuttle, Daniel Walker, William D. Steers, Richard McCarty, Chris Bushe, Michael H. Ossipov, Todd Sherer, John M. Spitsbergen, Karl‐Erik Andersson and Helen Hochstetler and has published in prestigious journals such as PLoS ONE, Brain Research and The Journal of Urology.

In The Last Decade

David B. Clemow

37 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David B. Clemow United States	16	427	207	169	135	128	40	883
P. Gary Katz United States	14	388 0.9×	123 0.6×	45 0.3×	96 0.7×	60 0.5×	28	863
Zongshi Qin China	19	133 0.3×	108 0.5×	110 0.7×	22 0.2×	91 0.7×	66	996
W. Poewe Germany	15	123 0.3×	50 0.2×	144 0.9×	165 1.2×	136 1.1×	49	826
Maria L. Zorzitto Canada	9	368 0.9×	68 0.3×	124 0.7×	60 0.4×	362 2.8×	21	797
Lucy A. Templeman United Kingdom	9	250 0.6×	132 0.6×	19 0.1×	152 1.1×	115 0.9×	10	580
Laurent Alexandre France	23	698 1.6×	530 2.6×	20 0.1×	61 0.5×	84 0.7×	41	1.1k
Thomas Noack Germany	15	116 0.3×	41 0.2×	78 0.5×	173 1.3×	111 0.9×	40	735
Sharon P. Viosca United States	16	360 0.8×	126 0.6×	30 0.2×	87 0.6×	106 0.8×	24	1.1k
F.S. Abuzzahab United States	11	395 0.9×	27 0.1×	89 0.5×	95 0.7×	26 0.2×	25	756
Maja Relja Croatia	19	305 0.7×	10 0.0×	94 0.6×	325 2.4×	356 2.8×	41	1.3k

Countries citing papers authored by David B. Clemow

Since Specialization

Citations

This map shows the geographic impact of David B. Clemow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Clemow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Clemow more than expected).

Fields of papers citing papers by David B. Clemow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Clemow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Clemow. The network helps show where David B. Clemow may publish in the future.

Co-authorship network of co-authors of David B. Clemow

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Clemow. A scholar is included among the top collaborators of David B. Clemow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Clemow. David B. Clemow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clemow, David B., Marla C. Dubinsky, Simin Baygani, et al.. (2025). Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab. Journal of Patient-Reported Outcomes. 9(1). 75–75.

Sands, Bruce E., Geert D’Haens, David B. Clemow, et al.. (2024). Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. Inflammatory Bowel Diseases. 31(7). 1876–1890. 14 indexed citations

Sands, Bruce E., Geert D’Haens, David B. Clemow, et al.. (2024). Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. Inflammatory Bowel Diseases. 30(12). 2245–2258. 26 indexed citations

Sands, Bruce E., Geert D’Haens, David B. Clemow, et al.. (2023). S848 Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment: Interim Results From the LUCENT-3 Open-Label Extension Study. The American Journal of Gastroenterology. 118(10S). S627–S627. 1 indexed citations

Clemow, David B., Helen Hochstetler, Yanhong Dong, et al.. (2021). Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine. Postgraduate Medicine. 133(4). 449–459. 4 indexed citations

Clemow, David B., et al.. (2020). Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two phase 3 randomized clinical trials. Current Medical Research and Opinion. 36(11). 1791–1806. 8 indexed citations

Clemow, David B., Kirk W. Johnson, Helen Hochstetler, et al.. (2020). Lasmiditan mechanism of action – review of a selective 5-HT1F agonist. The Journal of Headache and Pain. 21(1). 71–71. 91 indexed citations

McBurnett, Keith, David B. Clemow, David W. Williams, et al.. (2016). Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms. Journal of Child and Adolescent Psychopharmacology. 27(1). 38–42. 20 indexed citations

Clemow, David B., Elias Sarkis, Dustin Ruff, et al.. (2015). Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study. Expert Review of Neurotherapeutics. 15(11). 1353–1366. 3 indexed citations

10.

Clemow, David B.. (2015). Misuse of Methylphenidate. Current topics in behavioral neurosciences. 34. 99–124. 38 indexed citations

11.

Clemow, David B., et al.. (2015). Medicines in Pregnancy Forum: Proceedings on Ethical and Legal Considerations. Therapeutic Innovation & Regulatory Science. 49(3). 326–332. 2 indexed citations

12.

Clemow, David B. & Daniel Walker. (2014). The Potential for Misuse and Abuse of Medications in ADHD: A Review. Postgraduate Medicine. 126(5). 64–81. 115 indexed citations

13.

Clemow, David B., et al.. (2014). Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving Forward. Therapeutic Innovation & Regulatory Science. 48(2). 134–144. 2 indexed citations

14.

Adler, Lenard A., David B. Clemow, David W. Williams, & Todd M. Durell. (2014). Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study. PLoS ONE. 9(8). e104175–e104175. 23 indexed citations

15.

Clemow, David B., et al.. (2014). A Proposed Framework to Address Needs of Clinical Data for Informed Medication Use in Pregnancy. Therapeutic Innovation & Regulatory Science. 48(2). 145–154. 5 indexed citations

16.

Andersen, Scott W., David B. Clemow, & S. Corya. (2005). Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder. The Journal of Clinical Psychiatry. 66(11). 1468–1476. 38 indexed citations

17.

Sherer, Todd, David B. Clemow, & Jeremy B. Tuttle. (1999). Calcium homeostasis and nerve growth factor secretion from vascular and bladder smooth muscle cells. Cell and Tissue Research. 299(2). 201–211. 4 indexed citations

18.

Steers, William D., David B. Clemow, Katarina Persson, et al.. (1999). The spontaneously hypertensive rat: insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Experimental Physiology. 84(1). 137–147. 96 indexed citations

19.

Clemow, David B. & Jeremy B. Tuttle. (1998). Effects of growth rate and cell density on nerve growth factor secretion in cultures of vascular and bladder smooth muscle cells from hypertensive and hyperactive rats. Cell and Tissue Research. 294(3). 431–438. 10 indexed citations

20.

Clemow, David B., Richard McCarty, William D. Steers, & Jeremy B. Tuttle. (1997). Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats. Neurourology and Urodynamics. 16(4). 293–303. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact